School of Medicine
Showing 1-4 of 4 Results
John D. Mark
Clinical Professor, Pediatrics - Pulmonary Medicine
BioDr. Mark received his medical degree from the University of Kansas and completed his residency in pediatrics at Children’s Mercy Hospital in Kansas City, Missouri. He then completed a fellowship in pediatric pulmonary medicine at the University of Rochester, Rochester, New York. In 1999, Dr. Mark completed the first fellowship in Pediatric Integrative Medicine at the University of Arizona. He practices at Packard Children’s Hospital where he utilizes non-conventional approaches with patients who have chronic illnesses such asthma and cystic fibrosis. He is interested in nutrition and the mind/body approach to healing in an effort to decrease dependence on medication.
Dr. Mark is the Program Director for the Pediatric Pulmonary fellowship program, Associate Director for the Pediatric residency program and the Medical Director for the Coordinating and Optimizing Resources Effectively (CORE) Program at Packard Children’s Hospital, Stanford University. This innovative program assists with care coordination and communication with all health care providers for children with complex medical needs.
Professor of Pediatrics (Pulmonary Medicine) and, by courtesy, of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsMy research interests have centered on the inflammatory responses that lead to airway disease in Cystic Fibrosis (CF) and the metabolic factors that contribute to CF lung disease progression. Current efforts are focused on the understanding of the early events that drive the development of lung disease through the study of infants with CF identified by newborn screening. This includes the development of new diagnostic tools that permit the early detection of lung disease manifestations.
Richard B. Moss
Professor of Pediatrics at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsImmunopathogenesis of chronic airways diseases of childhood, including cystic fibrosis, asthma, allergic aspergillosis and bronchopulmonary dysplasia. Translational research: early clinical trials in airways disease of childhood, most notably CF, including gene, cytokine and drug therapy. Recent projects focus on development of biomarkers and treatments for allergic fungal lung disease, e.g. inhaled antifungals.